CEREBRAL SOMATIC OXIMETERS MARKET ANALYSIS

Cerebral Somatic Oximeters Market, By Product Type (Dual Emitter and Dual Detector, Single Emitter and Dual Detector, and Others), By Patient Type (Pediatrics, Adults, and Others) By Application (Cardiac Surgery, Vascular Surgery, and Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Cerebral Somatic Oximeters Market: Key Developments

Increasing product approvals by regulatory authorities is expected to drive the global cerebral somatic oximeters market growth over the forecast period. For instance, in August 2020, Masimo, a global medical technology company, announced that O3 Regional Oximetry has received Food and Drugs Administration (FDA) clearance for expanded use in monitoring somatic tissue oxygenation saturation in all patient populations and monitoring relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.
In December 2021, Medtronic, a global leader in healthcare technology, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS 7100 cerebral/somatic oximetry system for children from birth through age 18.